Download the Whitepaper

The Medpace Advantage for Nephrology Clinical Trials

With decades of experience conducting phase I-IV nephrology clinical trials, Medpace is a globally recognized leader in renal clinical research. We understand the complexities of renal disease trials from the perspective of the Sponsor, the clinical investigator, the scientific leader, and the reviewer at regulatory agencies.

You benefit from:

• In-house board-certified nephrologists with 40+ years of experience in clinical drug development, responsible for leading several drugs from early phase development through product launch
• Extensive global clinical trial experience in numerous nephrology indications
• Deep, long-standing relationships with nephrology KOLs and sites, along with preferred partnerships with key site networks that streamline study start-up, enhance patient recruitment, and ensure high-quality data capture
• A fully integrated solution with our in-house imaging core lab and global central lab to maximize efficiency